Hummingbird Healthcare Secures $20M to Optimize Patient Access
What You Should Know: – Hummingbird Healthcare Inc., a provider of managed services for patient access in healthcare, today announced a $20M Series B funding round led by Health Velocity Capital. – The investment will support Hummingbird’s mission to modernize patient access, improve operational efficiency, and enhance the patient experience for health systems across the ... Read More


What You Should Know:
– Hummingbird Healthcare Inc., a provider of managed services for patient access in healthcare, today announced a $20M Series B funding round led by Health Velocity Capital.
– The investment will support Hummingbird’s mission to modernize patient access, improve operational efficiency, and enhance the patient experience for health systems across the country.
Addressing the Challenges of Patient Access
Patient access is a critical component of healthcare delivery, but it is often plagued by inefficiencies, long wait times, and frustrating experiences for both patients and providers. Hummingbird specializes in optimizing patient access services, including appointment scheduling, registration, insurance verification, and more.
Hummingbird’s managed services address these patient access challenges by:
- Centralizing operations: Consolidating patient access services into centralized contact centers for improved efficiency and consistency.
- Optimizing technology: Leveraging technology to streamline workflows, automate tasks, and enhance the patient experience.
- Improving staff engagement: Creating a positive and supportive work environment for patient access staff, leading to better retention and performance.
“From the beginning, we knew that both healthcare systems and patients wanted a more logical and humane access experience,” said Jeremy Schwach, Hummingbird’s CEO. “The pace of Hummingbird’s growth and our clients’ trust demonstrate just how huge that need is.” Hummingbird’s current round of investment follows closely a Series A round that closed in June 2024.